Hypertrophic osteoarthritis and Dupuytren's contracture

Summary:

Dupuytren's contracture is found among people with Hypertrophic osteoarthritis, especially for people who are female, 60+ old.

The study analyzes which people have Dupuytren's contracture with Hypertrophic osteoarthritis. It is created by eHealthMe based on reports of 7 people who have Hypertrophic osteoarthritis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On May, 29, 2022

7 people who have Hypertrophic Osteoarthritis and Dupuytren'S Contracture are studied.


What is Hypertrophic osteoarthritis?

Hypertrophic osteoarthritis (arthritis associated with inflammatory bowel disease or following bacterial infection of the bowel) is found to be associated with 3,105 drugs and 2,477 conditions by eHealthMe.

What is Dupuytren's contracture?

Dupuytren's contracture (thickening of the fibrous tissue layer underneath the skin of the palm and fingers) is found to be associated with 445 drugs and 208 conditions by eHealthMe.

Number of Dupuytren's contracture in Hypertrophic osteoarthritis reports submitted per year:

Would you have Dupuytren's contracture when you have Hypertrophic osteoarthritis?

Gender of people who have Hypertrophic Osteoarthritis and experienced Dupuytren'S Contracture *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Hypertrophic Osteoarthritis and experienced Dupuytren'S Contracture *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 14.29 %
  • 60+: 85.71 %

Common co-existing conditions for these people *:

  1. Sleep Disorder: 1 person, 14.29%
  2. Pain: 1 person, 14.29%
  3. Migraine (headache): 1 person, 14.29%
  4. Affective Disorder (mental disorder): 1 person, 14.29%

Common drugs taken by these people *:

  1. Zoledronic Acid: 6 people, 85.71%
  2. Zopiclone: 1 person, 14.29%
  3. Panadol: 1 person, 14.29%
  4. Oxycodone: 1 person, 14.29%
  5. Escitalopram: 1 person, 14.29%

Common symptoms for these people *:

  1. Weakness: 6 people, 85.71%
  2. Tendonitis (a condition that causes pain and swelling of tendons): 6 people, 85.71%
  3. Pain In Extremity: 6 people, 85.71%
  4. Joint Pain: 6 people, 85.71%
  5. Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 1 person, 14.29%
  6. Lip Swelling: 1 person, 14.29%
  7. Irritability: 1 person, 14.29%
  8. Emotional Disorder: 1 person, 14.29%
  9. Burning Sensation: 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Dupuytren's contracture?

Check whether Dupuytren's contracture is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Dupuytren's contracture:

Common drugs associated with Dupuytren's contracture:

All the drugs that are associated with Dupuytren's contracture:

Common conditions associated with Dupuytren's contracture:

  • Ra: 104 reports

All the conditions that are associated with Dupuytren's contracture:

How the study uses the data?

The study is based on Dupuytren's contracture and Hypertrophic osteoarthritis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: